Please login to the form below
CNS
This page shows the latest CNS news and features for those working in and with pharma, biotech and healthcare.
Celgene bulks up pipeline again with $2.1bn Prothena deal
It’s also been working with Evotec on therapies for neurodegenerative disorders using the German biotech’s stem cell screening platform, and has accelerated its R&D efforts in CNS after
Latest news
-
Boehringer abandons PDE-targeted Alzheimer’s drug
progress in this area, ”said Jan Poth, head of CNS and Immunology research at Boehringer. ... It is currently planning phase II trials of BI 425809, a glycine transport (glyt1) inhibitor that also affects the glutamate pathways in the central nervous
-
Pfizer drops neuroscience R&D, cutting 300 jobs
chronic pain associated with osteoarthritis Lyrica (pregabalin) for fibromyalgia, as well as CNS-targeting drugs in its rare disease programme.
-
Shire suffers pipeline failure as takeover speculation builds
The setback removes around $200m in potential sales of the drug, which the analysts says has $700m global sales potential as a non-CNS treatment.
-
Boehringer adds to pipeline again with €628m Autifony CNS deal
Boehringer adds to pipeline again with 628m Autifony CNS deal. Bags rights to the GlaxoSmithKline spin-out's small-molecule drug for schizophrenia. ... Preclinical work also suggests potential in hearing disorders, says Boehringer. The company’s head
-
Bayer gets clinical data to support $1.5bn Loxo deal
A phase 2 portion of the paediatric study in infantile fibrosarcoma and other TRK fusion cancers - both CNS and non-CNS - is now getting underway at a recommended dose of
More from news
Approximately 4 fully matching, plus 161 partially matching documents found.
Latest Intelligence
-
A quest for innovative solutions
PRISM has matured into an artery of new opportunities such as its collaboration on RADAR-CNS (Remote Assessment of Disease and Relapse - Central Nervous System), an initiative that aims to develop
-
The good, the bad and the ugly
Pfizer has large sales in CNS - $8.5bn in 2017. The majority come through Lyrica ($5bn). ... In Europe, a patent dispute over Lyrica became arguably the biggest CNS story in recent years.
-
Pharma deals continue to slide
1, 410 (upfront 80). WuXi Biologics and Gloria Pharma (CN). Arcus Biosciences (US). ... 163. Mologen (DE). iPharma (CN). Binding term sheet for licensing and co-development.
-
Deal Watch - May 2017
Peptidream (CN). Janssen (US). Licence. Peptide discovery platform. Up to 1, 150.
-
Deal Watch September 2016
210. Ligand / Seelos. Licence. 4 programmes including aplindore for CNS disorders.
More from intelligence
Approximately 0 fully matching, plus 38 partially matching documents found.
Latest appointments
-
Damien McDevitt moves from GSK to Acadia Pharmaceuticals
At Acadia, which focuses on the development and commercialisation of medicines for central nervous system (CNS) disorders, McDevitt will report to the company’s president and chief executive officer Steve Davis. ... This expertise, combined with his
-
Ron Menezes joins Almirall’s Aqua Pharmaceuticals
Menezes joins the group from Depomed Pharmaceuticals, where he served as vice president of sales and sales operations, pain and CNS.
-
emotive boosts its client services team
Joining as a senior account director, Andy Parry has 9 years’experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.
-
Axon bolsters team with new PR Director hire
During her career, Smiddy has led local, regional and international programmes to support pharmaceutical products in numerous therapeutic fields including cardiology, immunology, CNS and oncology.
-
Therachon strengthens management team
He most recently served as a senior director at Lundbeck, leading the Danish firm's global biologics programme to treat CNS diseases, and before this held senior roles at Amplimmune and
More from appointments
Approximately 0 fully matching, plus 24 partially matching documents found.
Latest from PMHub
-
A fast-growing client services team at emotive.
Starting his career in Medical Education and then moving into healthcare advertising, Andy has worked on large global brands in CNS, infectious diseases, respiratory and rare diseases. ... Also with a Biomedical Science degree, Sabrina worked in
-
Sanofi on lack of customer understanding
We need to understand customer value and do it better than our competition" - Corinne Le Goof, VP CNS Marketing, Sanofi Aventis.
-
M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group
About M3:. M3 operates in Asia, the US and Europe with more than 4 million physician doctor members globally via M3.com, MDLinx, Medigate, medlive.cn, M3Medical and Doctors.net.uk.
-
New appointments announced across Research Partnership’s global offices
Marianne has over 15 years’ experience in healthcare marketing research. She has extensive experience in a variety of therapy areas including oncology, diabetes, autoimmune disorders, CNS, women’ s health and cardiovascular
-
M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group
About M3:. M3 operates in Asia, the US and Europe with more than 4 million physician doctor members globally via M3.com, MDLinx, Medigate, medlive.cn, M3Medical and Doctors.net.uk.
More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
-
Senior Programme Executive
-
Salary TBC
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Account Manager – Med Comms – London
-
Salary TBC
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Scientific Director
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
-
Senior Medical Writer
-
Great salary and bebefits
Subscribe to our email news alerts
PMHub
Dovetail
Transforming healthcare through effective collaboration. Making work to feel proud of.
www.dovetailstrategies.com...
Latest intelligence
- No incentive for a cure
- The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
Quick links
Infographics
